These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 17525649)

  • 41. Prevalence, progression, and impact of glaucoma on vision after Boston type 1 keratoprosthesis surgery.
    Talajic JC; Agoumi Y; Gagné S; Moussally K; Harissi-Dagher M
    Am J Ophthalmol; 2012 Feb; 153(2):267-274.e1. PubMed ID: 21982110
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outcomes of Boston keratoprosthesis in aniridia: a retrospective multicenter study.
    Akpek EK; Harissi-Dagher M; Petrarca R; Butrus SI; Pineda R; Aquavella JV; Dohlman CH
    Am J Ophthalmol; 2007 Aug; 144(2):227-231. PubMed ID: 17543875
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vitreoretinal surgery in eyes with Pintucci biointegrable keratoprosthesis.
    Rishi P; Maskati QB; Ray R; Iyer GK; Srinivasan B; Pillai VS
    Retina; 2010 Feb; 30(2):287-93. PubMed ID: 19881398
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Visual rehabilitation in end-stage inflammatory ocular surface disease with the osteo-odonto-keratoprosthesis: results from the UK.
    Liu C; Okera S; Tandon R; Herold J; Hull C; Thorp S
    Br J Ophthalmol; 2008 Sep; 92(9):1211-7. PubMed ID: 18511541
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Boston type 1 keratoprosthesis: the CHUM experience.
    Robert MC; Harissi-Dagher M
    Can J Ophthalmol; 2011 Apr; 46(2):164-8. PubMed ID: 21708085
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gamma-irradiated corneas as carriers for the Boston type 1 keratoprosthesis: advantages and outcomes in a surgical mission setting.
    Fadlallah A; Atallah M; Cherfan G; Awwad ST; Syed ZA; Melki SA
    Cornea; 2014 Mar; 33(3):235-9. PubMed ID: 24457451
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-Term Outcomes of the Boston Type I Keratoprosthesis in the Management of Corneal Limbal Stem Cell Deficiency.
    Aravena C; Bozkurt TK; Yu F; Aldave AJ
    Cornea; 2016 Sep; 35(9):1156-64. PubMed ID: 27387566
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Visual rehabilitation with keratoprosthesis after tenonplasty as the primary globe-saving procedure for severe ocular chemical injuries.
    Iyer G; Srinivasan B; Agarwal S; Barbhaya R
    Graefes Arch Clin Exp Ophthalmol; 2012 Dec; 250(12):1787-93. PubMed ID: 22546999
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vision-related function after scleral lens fitting in ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Tougeron-Brousseau B; Delcampe A; Gueudry J; Vera L; Doan S; Hoang-Xuan T; Muraine M
    Am J Ophthalmol; 2009 Dec; 148(6):852-9.e2. PubMed ID: 19837383
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Keratoprosthesis: current techniques.
    Aquavella JV; Qian Y; McCormick GJ; Palakuru JR
    Cornea; 2006 Jul; 25(6):656-62. PubMed ID: 17077656
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term Visual Outcomes and Complications of Boston Keratoprosthesis Type II Implantation.
    Lee R; Khoueir Z; Tsikata E; Chodosh J; Dohlman CH; Chen TC
    Ophthalmology; 2017 Jan; 124(1):27-35. PubMed ID: 27538795
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Visual Outcomes and Complications of Type I Boston Keratoprosthesis in Children: A Retrospective Multicenter Study and Literature Review.
    Fung SSM; Jabbour S; Harissi-Dagher M; Tan RRG; Hamel P; Baig K; Ali A
    Ophthalmology; 2018 Feb; 125(2):153-160. PubMed ID: 28807636
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glaucoma Management in Patients With Aniridia and Boston Type 1 Keratoprosthesis.
    Nascimento E Silva R; Shen LQ; Chiou CA; Shanbhag SS; Paschalis EI; Pasquale LR; Colby KA; Dohlman CH; Chodosh J; Alves MR
    Am J Ophthalmol; 2019 Nov; 207():258-267. PubMed ID: 31247168
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Boston type 1 keratoprosthesis for primary congenital glaucoma.
    Haugsdal JM; Goins KM; Greiner MA; Kwon YH; Alward WL; Wagoner MD
    Br J Ophthalmol; 2016 Mar; 100(3):328-31. PubMed ID: 26206789
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Boston type I keratoprosthesis assisted with intraprosthetic amniotic membrane (AmniotiKPro sandwich technique).
    Navas A; Hernandez-Camarena JC; Serna-Ojeda JC; Ramirez-Miranda A; Graue-Hernández EO
    Acta Ophthalmol; 2015 Feb; 93(1):e87-8. PubMed ID: 24797302
    [No Abstract]   [Full Text] [Related]  

  • 56. Structural & functional rehabilitation in eyes with lamina resorption following MOOKP--can the lamina be salvaged?
    Iyer G; Srinivasan B; Agarwal S; Shanmugasundaram S; Rajan G
    Graefes Arch Clin Exp Ophthalmol; 2014 May; 252(5):781-90. PubMed ID: 24604022
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Boston Type I keratoprosthesis: an assessment of its efficacy and safety.
    Verdejo-Gómez L; Peláez N; Gris O; Güell JL
    Ophthalmic Surg Lasers Imaging; 2011; 42(6):446-52. PubMed ID: 21919432
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Outcome of combined penetrating keratoplasty with vitreoretinal surgery using temporary Eckardt keratoprosthesis].
    Levy J; Kratz A; Klemperer I; Lifshitz T
    Harefuah; 2005 Nov; 144(11):781-4, 822. PubMed ID: 16358653
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Boston keratoprosthesis for keratopathy in eyes with retained silicone oil: a new indication.
    Iyer G; Srinivasan B; Gupta J; Rishi P; Sen PR; Bhende P; Gopal L; Padmanabhan P
    Cornea; 2011 Oct; 30(10):1083-7. PubMed ID: 21705878
    [TBL] [Abstract][Full Text] [Related]  

  • 60. International Outcomes of the Boston Type I Keratoprosthesis in Stevens-Johnson Syndrome.
    Alexander JK; Basak SK; Padilla MD; Yu F; Aldave AJ
    Cornea; 2015 Nov; 34(11):1387-94. PubMed ID: 26382898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.